Kent Meningitis Surge: 29 Cases, Students Queue for Vaccine

Meningitis Outbreak in Kent: Cases Rise to 29 Amidst Growing Concerns

Health officials have confirmed a concerning rise in meningitis cases linked to an ongoing outbreak in Kent, with the total number of infections now standing at 29. This significant increase follows the confirmation of two additional cases, according to the latest daily update from the UK Health Security Agency (UKHSA).

Of the 18 confirmed cases, 13 have been identified as caused by meningitis B (MenB). Alarmingly, all confirmed cases have necessitated hospital admission, underscoring the severity of the illness. The current figure of 29 represents a steady climb from previous days, with 27 reported yesterday, 20 on Wednesday, 15 on Tuesday, and 13 on Monday.

The outbreak has tragically claimed the lives of two young individuals: Juliette Kenny, an 18-year-old sixth-former at Queen Elizabeth’s Grammar School in Faversham, and an unnamed 21-year-old student from the University of Kent.

Breakdown of Cases Linked to the Kent Outbreak

Note: The distinction between confirmed and probable cases was not consistently reported in the early stages of the outbreak.

A Father’s Plea for Action and Lasting Change

The devastating loss of his daughter, Juliette, has spurred her father, Michael Kenny, to issue a heartfelt plea for enhanced protection measures for young people. Juliette passed away last Saturday, just one day after exhibiting initial symptoms including vomiting and discolouration on her cheeks. Mr. Kenny described his daughter as a vibrant and healthy young woman who had recently completed a practical assessment for her PE A-level.

“We are incredibly proud parents to two wonderful daughters. Juliette is a force in this world. With her beautifully positive energy she spread fun, love and happiness to those around her and she continues to do so now. The devastation of her loss to us, her family and friends is immeasurable.”

Mr. Kenny recounted the rapid progression of Juliette’s illness, noting that she had been well on Thursday, March 12th. By the early hours of Friday, March 13th, she experienced vomiting. A discolouration on her cheeks prompted her parents to take her to a local emergency drop-in centre, where she received antibiotics and was subsequently transported by ambulance to A&E. Despite a brave fight, Juliette succumbed to the illness less than 12 hours later, surrounded by her loved ones.

“No family should experience this pain and tragedy,” Mr. Kenny stated. “This can be avoided. There are young people currently battling this and young people still at risk. As parents, we knew our children would change the world and be a force for good. The work to protect young people has started. It needs to be more. Juliette’s impact on this world must be lasting change. Now is the time to ensure families are safe from the impact of meningitis B.”

The MenB Vaccination Gap and Calls for Routine Access

In solidarity with the Meningitis Research Foundation, the Kenny family is advocating for urgent action to improve access to the MenB vaccination for teenagers and young adults across the UK. Vinny Smith, chief executive of the Meningitis Research Foundation, highlighted that the charity’s calls for routine MenB vaccination for all at-risk age groups in 2015 were not pursued, reportedly due to cost-effectiveness assessments at the time.

The MenB jab was introduced for infants in 2015, leaving a significant cohort of young people born before this date unprotected unless they opt for private vaccination. The Kenny family, like many others, were unaware of this gap in routine NHS coverage for teenagers and young adults.

Mr. Smith urged the Government to prioritise saving lives and mitigating the lifelong disabilities associated with MenB. He expressed concern that previous assessments of the vaccine’s value failed to fully account for the severity of meningitis, its long-term consequences, and the profound trauma experienced by affected families.

“People across the country will have seen that impact this week; we believe the UK Government can decide now to save lives and limit the lifelong disabilities caused by meningitis, protecting people for generations to come.”

Overwhelmed Vaccination Clinics and Expert Insights

The surge in cases has led to an overwhelming demand for vaccinations, with reports of over 100 students being turned away from a clinic at the University of Kent due to capacity issues. The university has since reopened its vaccination clinic, advising individuals to join the queue early.

Professor Dominic Abrams, a social psychology professor at the University of Kent, observed that the scenes outside the vaccination clinic were “very reminiscent of Covid,” causing understandable concern and anxiety among students. However, he noted that the current situation, while serious, is “more under control” than during the pandemic.

Professor Robin May, chief scientific officer of the UKHSA, attributed the clinic’s capacity issue to a “staffing issue” rather than a shortage of vaccine. He clarified that while immediate protection for exposed individuals is provided through prophylactic antibiotics, the current vaccination efforts are for follow-up protection. He stressed that students on antibiotics are already protected and that a delay of a day or two in receiving the vaccine does not pose an immediate health risk.

Investigating the Outbreak’s Unusual Nature

Professor May described the outbreak as “very unusual,” with experts investigating potential factors contributing to its increased transmissibility. These investigations include:

• Environmental factors: Exploring whether specific settings, such as a particular club, may have facilitated the spread of the bacteria.
• Bacterial changes: Examining if the bacteria itself has mutated, becoming more transmissible or more likely to cause disease.

Genome sequencing of the strain is underway, a complex process given the bacteria’s size. Professor May acknowledged the possibility of such an outbreak reoccurring and emphasised the importance of learning from this event to develop better preventative strategies for the future.

He also stressed the need for vigilance across the country, advising anyone experiencing symptoms such as a rapid high fever, a non-blanching rash, aversion to light, stiff neck, or flu-like symptoms to seek medical help immediately without delay.

International Case and Government Response

In an unrelated development, an employee at a French nuclear fuel company in Normandy died of meningitis. The company stated there is no evidence linking this case to the UK outbreak. Local authorities have implemented preventive measures, including antibiotic treatments and isolation for close contacts.

In response to the escalating situation in Kent, Health Secretary Wes Streeting announced that individuals who attended the venue Club Chemistry between March 5th and March 15th will be offered the MenB vaccine. This offer extends to sixth-formers at four local schools and other university students in Canterbury. Additional vaccination clinics have opened across Kent, and eligible individuals across England can now access vaccinations and antibiotics from their local GP.

The UKHSA has made 20,000 vaccines available to the private market to alleviate demand at pharmacies.

Dr. Anjan Ghosh, Kent County Council’s director of public health, stated that it is not yet possible to definitively confirm if the outbreak has been contained.

Olivia Parkins, a member of the University of Kent’s cheerleading society, reported three confirmed cases within the group, all of whom are hospitalised. A Morrisons employee who attended Club Chemistry has also contracted meningitis.

Furthermore, approximately 40 Members of Parliament have signed a letter to the Health Secretary, urging the Government and health officials to collaborate with universities on catch-up vaccination programmes and enhance public awareness. They have also called for an accelerated review of eligibility criteria for meningitis vaccines.